In conclusion, TGF-β inhibits the expression of SDPR in gastric cancer, relieves the inhibitory effect of SDPR on the protein level of ERK, and promotes the expression of the transcription factor PPARα, thereby upregulating the expression of CPT1A at the transcriptional level, promoting FAO and inducing gastric cancer metastasis. Here, CPT1A is linked to gastric cancer.